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During retroviral RNA encapsidation, two full-length
genomic (g) RNAs are selectively incorporated into
assembling virions. Packaging involves a cis-acting
packaging element (J) within the 50 untranslated
region of unspliced HIV-1 RNA genome. However,
the mechanism(s) that selects and limits gRNAs for
packaging remains uncertain. Using a dual comple-
mentation system involving bipartite HIV-1 gRNA,
we observed that gRNA packaging is additionally
dependent on a cis-acting RNA element, the
genomic RNA packaging enhancer (GRPE), found
within the gag p1-p6 domain and overlapping the
Gag-Pol ribosomal frameshift signal. Deleting or dis-
rupting the two conserved GRPE stem loops dimin-
ished gRNA packaging and infectivity >50-fold, while
deleting gag sequences between J and GRPE had
no effect. Downregulating the translation termination
factor eRF1 produces defective virus particles con-
taining 20 times more gRNA. Thus, only the HIV-1
RNAs employed for Gag-Pol translation may be
specifically selected for encapsidation, possibly ex-
plaining the limitation of two gRNAs per virion.
INTRODUCTION
Retroviral RNA encapsidation is a highly ordered process by
which two full-length genomic (g) RNAs are incorporated into
assembling virions. Although a single gRNA template can
support retroviral reverse transcription and proviral DNA
synthesis (Hu and Temin, 1990), recombination and reassort-
ment of polymorphisms is a hallmark feature of the retrovirus
and dependent on a diploid genome. Prior to packaging, inter-
genomic annealing initiates formation of loose noncovalent
dimers of unspliced HIV-1 RNA, which is then selected for
encapsidation over the excess host cellular and viral spliced
HIV-1 RNAs (99% of the total cellular RNA). This selectivity is
due to the recognition of a cis-acting packaging element within
the 50 untranslated region (50UTR) by the nucleocapsid (NC)Cell Host &domain of the Gag polyprotein via two zinc fingers (Berkowitz
et al., 1996; Rein, 1994; D’Souza and Summers, 2005). Confocal
microscopy studies suggest that the capture of gRNA by Gag
occurs in a perinuclear/centrosomal site. A single interaction
with gRNA may nucleate Gag multimerization during assembly
(Burniston et al., 1999; Kutluay and Bieniasz, 2010), or multiple
Gag proteins may preassemble into oligomeric arrays in
the cytoplasm prior to gRNA binding (Swanson and Malim,
2006). It remains unclear why only one gRNA dimer is bound to
one of 2,000 Gag dimers forming new virus particles (Davis
and Rueckert, 1972) rather than one gRNA dimer per Gag
protein.
Secondary and tertiary structures of retroviral gRNAs in the
50UTR as well as proximal coding regions are involved in gRNA
dimerization, packaging, and translation (Lu et al., 2011;
Damgaard et al., 2004; Abbink and Berkhout, 2003). In HIV-1,
the canonical packaging signal (also referred to as psi or J)
contains four stem loops (SL1–SL4) located downstream of the
primer binding site (PBS) and extending into the 50 terminus of
gag coding sequences (Lever et al., 1989; Aldovini and Young,
1990). In particular, SL1 contains the dimerization initiation site
(DIS) which forms the kissing loop for gRNA dimerization (John-
son and Telesnitsky, 2010; Skripkin et al., 1994). Both SL2
(containing the splice donor site) and SL3 have high affinity for
NC (Amarasinghe et al., 2000), but only SL3 is recognized
as the core packaging element containing the highly conserved
GGAG NC-binding sequence (De Guzman et al., 1998). In com-
plex retroviruses such as HIV-1, gRNA packaging and dimeriza-
tion signals map to multiple sequences in both LTRs and the 50
end of gag, including the trans-activating-responsive (TAR)
stem loop and PBS (Russell et al., 2003; McBride and Pangani-
ban, 1996; Clavel and Orenstein, 1990). Despite attempts to
define the complete HIV-1 gRNA packaging signal, the relative
role of each sequence within HIV-1 genome has remained
debatable.
Understanding lentivirus gRNA packaging is important
to aspects of HIV-1 replication/pathogenesis, development of
drug targets, and enhancement of lentiviral gene delivery or
vaccine efficacy. In this study, the HIV-1 g/mRNA was sub-
divided into two subgenomic (sg) RNA species where both
contain at least J required for encapsidation. Only one sgRNA
acts as a template for reverse transcription such that muta-
tions/deletions in this RNA can be evaluated for effects onMicrobe 13, 181–192, February 13, 2013 ª2013 Elsevier Inc. 181
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Figure 1. Complementation System Used for Packaging Studies and Infectious Virus Production
(A) Series of pREC-50LTRHIV-1 vectors were constructed to express incremental lengths of HIV-1 subgenomic (sg) RNA. The plasmid depicted in orange harbors
the 50LTR followed by various HIV-1 coding sequence. The pREC-nfl-30LTR (near full length or nfl) HIV-1 vector (in blue) lacks the 50LTR and is used to cotransfect
293T cells and complement the pREC-50LTR. (B) Both vectors express 50-capped, 30 poly(A) HIV-1 mRNA species for the full complement HIV-1 proteins in the
cells and produce virus particles indistinguishable from those derived for transfection with full-length proviral DNA constructs (e.g., pNL4-3) (Dudley et al., 2009).
293T transfectants produce three virus types (C) containing either two 50LTR sgRNAs (x), two nfl-30LTR sgRNAs (y), or one of each (heterodiploid or xy). As
described in Figure S2, the 50LTR and nfl-30LTR sgRNAs in the heterodiploid virus can complement each other during reverse transcription to generate a WT,
full-length proviral DNA where the coding sequence is only derived from the nfl-30LTR. At 48 hr posttransfection, virus produced from 293T cells transfected with
pREC-nfl-30LTR and pREC-50LTR was monitored by western blots using anti-p24 and anti-b actin (as control for cellular protein expression) in cell lysates or in
virus-containing supernatants (D). (E) Virus production was also measured in supernatants by measuring RT activity using a radiolabelled assay or by quantifying
CA p24 using an antigen capture assay. Data are presented as mean ± SEM. See also Figure S2.
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Using this system, efficient gRNA encapsidation maps to two
general regions: J in the 50UTR and a genomic RNA packaging
enhancer (or GRPE) element which overlaps with the ribosomal
frameshift site (1,200 nt downstream from J). A programmed
1 nt ribosome frameshifting occurs at the Gag-Pol ribosomal
frameshift signal (RFS) of unspliced HIV-1 mRNA during Gag
translation, leading to production of the Gag-Pol precursor
protein (Jacks et al., 1988; Wilson et al., 1988). Recently, the
ribosomal stimulatory hairpin structure in HIV-1 RFS (Dulude
et al., 2002) or P3 stem loop (P3SL) as well as stable stem loop
(P2 stem loop or P2SL) has been defined by SHAPE RNA struc-
ture analyses (Watts et al., 2009). Inmost retroviruses (aside from
lentiviruses), a similar region at the 30 terminus of gag forms
a pseudoknot that regulates ribosomal pausing (Jacks et al.,
1988). Our findings now suggest a possible coregulation of
HIV-1 Gag-Pol translation and gRNA packaging during virus
production and assembly.182 Cell Host & Microbe 13, 181–192, February 13, 2013 ª2013 ElseRESULTS
An HIV-1 Replication System Involving Bipartite HIV-1
gRNA Where Only One Contributes to the Coding
Sequence
Research on gRNA packaging has focused primarily on signa-
ture RNA sequences or secondary structures in the 50UTR (Lever
et al., 1989; Clavel and Orenstein, 1990; Lu et al., 2011; McBride
and Panganiban, 1996). Mapping potential RNA packaging
elements within the HIV-1 coding region is more challenging,
considering confirmatory mutagenesis requires synonymous
substitutions to maintain the proteome while altering RNA struc-
ture/sequence. For these reasons, we cotransfected the 293T
producer cells with the two plasmids expressing two sgRNAs
(Dudley et al., 2009) (Figures 1A and 1B). Briefly, the minimal
CMV promoter in pREC-50LTR-nfl expresses a sgRNA starting
from R (nt 456; HXB2 genome numbering) and ending prior to
U3 (Nef-8902nt) with the BGH poly(A) (Figure 1A, last plasmidvier Inc.
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A Genomic RNA Packaging Element in Retrovirusesand RNA depicted in orange), whereas the complementing
vector pREC-nfl-30LTR expresses sgRNA starting at PBS and
ending with the U3-R, and HIV-1 poly(A) (termed 30LTR for this
article) (Figures 1A and 1B, plasmid and RNA depicted in blue).
HIV-1 mRNA expression from the CMV promoter may be slightly
reduced from that observed from the HIV-1 LTR promoter, but
the 50LTR-nfl still contains the TAR sequence and is stimulated
by Tat. In contrast, the nfl-30LTR lacks the TAR involved in abor-
tive transcription.
Both sgRNAs from pREC-50LTR-nfl and pREC-nfl-30LTR are
derived from the NL4-3 clone, harbor J, and can act as
mRNA templates for translation of HIV-1 structural proteins in
transfected cells. As expected, the truncated 50LTR sgRNAs
did not produce truncated Gag precursor proteins in the cells
(see Figure S1 online). If both the 50LTR-nfl and nfl-30LTR
sgRNAs are encapsidated at equal efficiencies, 50% of the
virus particles will be heterodiploid for both sgRNAs (based
on Hardy-Weinberg equilibrium X2+Y2+2XY) (Figure 1C) (Dudley
et al., 2009). Due to lack of the U3-R or R-U5 sequences,
homodiploid viruses with two copies of 50LTR-nfl or nfl-30LTR
sgRNAs are unable to complete reverse transcription following
de novo entry into a host cell (depicted in Figures S2A–S2C). In
contrast, infection with the heterodiploid virus leads to comple-
tion of reverse transcription, reconstitution of a full-length wild-
type (WT) genome, and proviral DNA integration (Figures S2A
and S2D).
The entire HIV-1 proteome originates from the nfl-30LTR
sgRNA following de novo infection with heterodiploid virus,
whereas the 50LTR-nfl sgRNA only serves a template for
tRNALys,3 binding and synthesis of () strand strong-stop DNA
(Figure S2D). As described below, we have introduced some
large deletions, multiple point mutations, and insertions into
the coding region of 50LTR-nfl sgRNA without impacting on
RNA packaging or infectivity, whereas other mutations have
significant effects. Although the elongating HIV-1 DNA during
reverse transcription could jump between the nfl-30LTR and
50LTR-nfl sgRNA templates, our high level of infectivity with or
without deletions suggests that these recombination events
occur at a relatively low frequency (estimated at 10%) (Dudley
et al., 2009).
Locating cis-Acting RNA Elements in the HIV-1 Coding
Sequence Necessary for gRNA Encapsidation
When pREC-nfl-30LTR construct was cotransfected with the
pCMV_cplt construct (expressing a short sgRNA containing
R-U5-PBS-MA) in a previous study, the resulting virus was mini-
mally infectious compared toWTNL4-3 virus (<0.01% infectivity)
(Dudley et al., 2009). Although the absolute level of viral RNAwas
similar to that in WT HIV-1 particles, we determined that this
reduced infectivity was attributable to poor packaging of this
short 50LTR sgRNA compared to the nfl-30LTR sgRNA, despite
the fact that both sgRNAs harbored J. As described below,
we noticed that WT infectivity was rescued by extending the
short 50LTR sgRNA to a near full-length HIV-1 RNA genome.
Based on these observations, we surmised that a previously
unrecognized site within the coding sequence of the HIV-1
genome was necessary for efficient RNA packaging.
To crudely map the coding region that contributes to gRNA
packaging, we deleted incremental amount of segments fromCell Host &the 30 terminus of proviral genome within the pREC-50LTR-nfl
vector to produce sgRNA (upon transfection) starting with
the R-U5 but ending at Nef8902, RT2845, PR2549, p62292, NC2085,
CA1878, CA1415, or MA1208 (Figure 1A, see Table S1 for HXB2
genomic RNA numbering). For all cotransfections, Gag protein
expression in cells and capsid (CA) in viruses were monitored
by western blot and ELISA (Figures 1D and 1E), and RT activity
was measured in the cell-free supernatant (Marozsan et al.,
2004) (Figure 1E). Transfections with pREC-nfl-30LTR alone or
cotransfections of the pREC-nfl-30LTR with the various pREC-
50LTR vectors produced similar amounts of virus based on RT
activity (Figure 1E).
A stock of WT NL4-3 HIV-1 and virus derived from 293T trans-
fections were serially diluted to measure RT activity and to infect
U87-CD4-CXCR4 cells (Figures 2A, 2C, and 2D). We have previ-
ously shown that RT activity of a WT HIV-1 stock is a strong
correlate of its infectious titer (Marozsan et al., 2004). Based on
the linear regression equation from RT activity versus infectious
titer of an NL4-3 virus stock (Figure 2B), we estimated that each
virus from cotransfections would have a similar infectious titer as
shown in Figure 2E. However, the actual serial dilution/infection
in U87-CD4-CXCR4 revealed a significant drop in infectious
titer with viruses that should have contained the shorter 50LTR
(NC2085, CA1878, CA1415, or MA1208) sgRNA compared to the
longer 50LTR (Nef8902, RT2845, PR2549, and p62292) sgRNA (Fig-
ure 2F). Based on this deletion mapping, it appears that a
207 nt sequence within the p1–p6 coding region (between
NC2085 and p62292 in the 5
0LTR sgRNA) was responsible for
a >350-fold increase in infectious titers. Even inclusion of
another 6,600 nt of sequential HIV-1 genome sequence on the
50LTR sgRNA (e.g., Nef 8902; Figure 1A) failed to further increase
infectivity (Figure 2F). However, shortening the 50LTR sgRNA
from NC2085 to CA1878 (Figure 1A) resulted in an additional
10-fold loss of infectivity, i.e., >3,000-fold less infectious than
the heterodiploid virus potentially containing the 50LTR-p62292
and nfl-30LTR sgRNAs (Figure 2F).
The GRPE RNA Element Is Necessary for Infectivity via
Effects on gRNA Packaging
Since reduced infectivity with the 50LTR sgRNA truncations was
not due to disruption of virus particle formation or release, we
suspected that gRNA encapsidation might have been compro-
mised. First, we confirmed that 50LTR and 30LTR sgRNAs were
efficiently expressed in the cells by showing that cellular-associ-
ated viral sgRNA levels, normalized to 18S ribosomal RNA levels,
were not affected by the length of the 50LTR sgRNA (Figure S3B).
Encapsidation of both sgRNAs can be measured using quantita-
tive reverse transcriptase PCR (qRT-PCR) with 50LTR- and
30LTR-specific primers and probes (Figure 3A). To ensure that
viral RNAs were transported from the nucleus, cells were parti-
tioned into cytoplasmic and nuclear fractions. The presence of
only spliced b-actin mRNA in the cytoplasmic fraction confirmed
efficient separation from the nuclear fraction (Figure S3A). There
were, however, abundant and similar levels of the unspliced
50LTR sgRNAs and nfl-30LTR sgRNA in the cell cytoplasm (Fig-
ure S3C). HIV-1 Rev binding to the Rev-responsive element
(RRE) in the env gene rescues unspliced and partially spliced
HIV-1 RNA transcripts from the nucleus for transport to the cyto-
plasm. It is unlikely that Rev would increase transport of theMicrobe 13, 181–192, February 13, 2013 ª2013 Elsevier Inc. 183
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Figure 2. Comparing the Expected and Actual Infectious Titers of Virus Derived from Cotransfected 293T Cells
(A) Wild-type NL4-3 HIV-1 was serially diluted (1:4) and used to measure RT activity and to infect U87.CD4.CXCR4. (B) RT activity was plotted against the level of
virus production for each dilution to determine a linear regression formula and to obtain as a surrogate of infectious titer (Marozsan et al., 2004). Virus produced
from the cotransfected 293T cells was diluted to measure RT activity (C) or to infect U87.CD4.CXCR4 cells (D). (E) provides the estimated infectious titers based
on analyses from (B) and (C). The actual TCID50 values (F) were derived from the serial dilution/infections of the U87.CD4.CXCR4 cells (D) using the standard
limiting protocol (Marozsan et al., 2004). The values are plotted at log10 infectious units/ml. See also Figure S1.
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lack the RRE as well as all known splice acceptor sites. In mono-
transfections with the pREC-50LTR vectors and in the absence of
Rev (provide by the pREC-nfl-30LTR), we still detected high
levels of unspliced HIV-1 RNA in cytoplasmic fractions (data
not shown).
The level of sgRNAs in virus was measured to determine
packaging efficiency of the different 50LTR sgRNAs (Figure 3B)
relative to nfl-30LTR sgRNA (Figure 3C). A dramatic shift was
observed in 50LTR sgRNA packaging when this RNA was
extended into the p6 region of the gag coding sequence
(27-fold increase in packaging of 50LTR-p62292 sgRNA pack-
aging over 50LTR-NC2085 sgRNA, respectively [Figure 3B]).
However, extension of the HIV-1 RNA genome beyond nt
2,292 (to near full length) did not augment gRNA packaging.
Relative encapsidation of the different 50LTR sgRNA directly
correlated with the level of virus infectivity (compare Figure 3B
and Figure 2F). Interestingly, the levels of efficient nfl-30LTR184 Cell Host & Microbe 13, 181–192, February 13, 2013 ª2013 ElsesgRNAs in virus particles remained relatively constant despite
reduced 50LTR sgRNA packaging (Figure 3C).
As a control, the AUG gag start codon was deleted in some of
the 50LTR sgRNAs (Figures 3D and 3E) such that any re-
combination would result in formation of dead virus, and yet
we did not observe an effect on RNA packaging or infectivity,
suggesting that this low-frequency recombination was not
affecting the primary results with our system.
Reduced HIV-1 Genomic RNA Encapsidation with GRPE
Deletion
Based on our truncation analyses, we mapped a putative
packaging determinant, designated the GRPE, to a 200–400 nt
RNA sequence at the 30 end of gag. To confirm the role of the
putative GRPE in genome encapsidation, two fragments
containing GRPE and surrounding sequences were deleted
from pREC-50LTR-RT2845 plasmid (Figure 4A). Encapsidation
of the 50LTR-RT2845 sgRNA with these GRPE deletions wasvier Inc.
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Figure 3. Relative Packaging of the HIV-1 Subgenomic RNA in Virus Derived from Cotransfected Cells
pREC-50LTR plasmids were used to transfect 293T cells along with pREC-nfl-30LTR. (A) Schematic representation of primers and probes used to specifically PCR
amplify and quantify the 50LTR sgRNA (orange) and nfl-30LTR sgRNA (blue) following cDNA synthesis (see Table S2 for primer details). Viral RNA was extracted
from cell-free supernatants of transfected cells. Copy numbers of 50LTR sgRNA (B) and nfl-30LTR sgRNA (C) were determined by qRT-PCR, compared to qRT-
PCR amplification of in vitro-transcribed HIV-1 RNA of known copy number (104 to 1010 copies), and presented as relative to the viral RT activity. Figure S3
presents the cytoplasmic and cellular levels of sgRNAs prior to packaging. (D) RNA packaging efficiency was not influenced by deletion of a Gag AUG start codon
in the 50LTR sgRNAs. Gag AUG initiation codon was deleted in the pREC-50LTR-CA 1878, NC2085, RT2845, and Nef8902. Viral RNA was extracted from cell-free
supernatants of transfected cells. Copy numbers of WT and DAUG 50LTR sgRNAs were determined by qRT-PCR and normalized to the viral RT activity. (E) Virus
infectivity was measured by first normalizing for RT activity, serially diluted as described in Figure 2D, and then added to U87.CD4.CXCR4 cells, i.e., a standard
TCID50 assay. The level of infectious virus is presented as log10 infectious units/ml. Data in (B)–(D) are presented as mean ± SEM. See also Figure S3.
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A Genomic RNA Packaging Element in Retrovirusesreduced >14-fold (Figure 4B), while the nfl-30LTR sgRNAs were
encapsidated at similar level (Figure S4A). The reduced 50LTR
sgRNA in the absence of the GRPE corresponded to a
>80-fold decrease in virus infectivity (Figure 4C). Based on 30
truncation and deletion analyses, we could map the GRPE to
200 nt between 1,956 nt and 2,188nt (RNA# 1,500 nt–1,732
nt) in the HIV-1 genome which also encompasses RFS. Again,
the 50LTR sgRNA neither contributes appreciably to HIV-1
protein production nor impacts virus particle formation and
release, but must be copackaged with the nfl-30LTR sgRNA for
subsequent virus propagation.
Investigating the impact of the GRPE deletion in the full-length
HIV-1 construct is problematic due to simultaneous deletion of
the Gag open reading frame, which prevents virus production.
To compensate, Gag and Gag-Pol proteins were provided in
trans from pCMVDR8.91 helper plasmid cotransfected with WT
and DGRPE pNL4-3 HIV-1. Due to the 30-Gag/GRPE deletion,
the virus derived from these 293T transfections was limited to
a single round of infection and could not be propagated as
with the bipartite genome system. Virus from transfections was
harvested, equalized for RT activity, and then lysed to measure
gRNA content. Virus particles derived from the WT versus
pNL4-3DGRPE contained 7-fold more gRNA (p < 0.001)
(Figure 4D).Cell Host &Positional Dependence ofGRPE for gRNAEncapsidation
To further map the GRPE, investigate its positional dependence,
and determine its minimal structure, sequences between the
GRPE and J in the 50LTR sgRNAs (ending at nucleotides
2,292, 2,270, and 2,183 in p6) were deleted by yeast recombina-
tion/gap repair to generate 50LTR-p6D868, D716, D706, and
D996 sgRNAs (Figure 4E). The resulting RNAs lack most of the
gag MA/CA/NC coding sequence but retain different p7/p1/p6
coding regions housing the GRPE. Packaging efficiencies and
infectivities were investigatedwith the bipartite genome/comple-
menting system. To better understand the behavior of these
gRNA constructs, domains within and around the GRPE were
structurally characterized using SHAPE (Watts et al., 2009),
which involves exposing RNAs to a reactive anhydride (1M7)
that selectively acylates ribose 20-OH moieties within flexible
(i.e., usually single-stranded) nucleotides. Sites of chemical
modification are subsequently detected as stops during reverse
transcription, and the products are fractionated by electropho-
resis. RNA secondary structures were predicted by introducing
constraints derived from chemical probing data into RNA struc-
ture (Mathews et al., 2004). Full-length in vitro-transcribed 50LTR
sgRNA constructs were used for structural probing, although
acylation profiles presented here are restricted to regions
involved in RNA packaging (Figure 4H).Microbe 13, 181–192, February 13, 2013 ª2013 Elsevier Inc. 185
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Figure 4. Effect of Deleting the Putative GRPE Element and the Region Separating GRPE andJ on Packaging of the 50LTR sgRNA
(A) The putative GRPEwas deleted as a 1,819–2,251 and 1,956–2,188 nt region in the p1–p6 coding regions of gagwithin the pREC-50LTR-RT2845, whichwas then
cotransfectedwith pREC-nfl-30LTR in 293T cells. A similar GRPE regionwas also deleted from theWTpNL4-3 construct and cotransfectedwith the pCMVDR8.91
vector (D). Finally, four regions were deleted separating the putative GRPE fromJ (E). The gRNAs were quantified in virus particles by qRT-PCR as described in
Figure 3 and presented as copies/ul in (B), (D), and (F) for the 50LTR sgRNAs (or NL4-3 gRNA) and for the nfl-30LTR sgRNA in Figure S4. Virus infectivity was
(legend continued on next page)
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A Genomic RNA Packaging Element in RetrovirusesQuantitation of the sgRNAs in virus particles revealed that the
868 nt deletion within the gag coding sequence of 50LTR sgRNA
(Figure 4E) had WT gRNA packaging levels. However, the
50LTR-MA1208 sgRNA, analogous to removal of the GRPE from
50LTR-p6D868 sgRNA, resulted in a 59-fold decrease in sgRNA
packaging (Figure 4F). Secondary structure analyses of 50LTR-
p6D868 sgRNA using SHAPE/RNAstructure (Mathews et al.,
2004) revealed that the structure of the RFS/GRPE (Figure 4H)
closely resembles the SHAPE-derived RNA structure obtained
using gRNA isolated from HIV-1 particles (Watts et al., 2009).
This structure is characteristic of a type C three-way junction
(Lescoute and Westhof, 2006) connecting a stem and two
stem loops (P2 and P3). P2SL contains the ‘‘slippery sequence’’
flanked at the 30 end by the continuous, P3SL, which is essential
for Gag-Pol ribosomal frameshifting (Dulude et al., 2002).
Surprisingly, deleting a smaller region in 50LTR-p6D706 and
50LTR-p6D716 sgRNA (Figure 4E) severely reduced sgRNA
packaging (Figure 4F) despite retaining the entire linear GRPE
sequence found in 50LTR-p6D868 sgRNA (with WT packaging
efficiency). In these cases, the 30 ends of the RNA in 50LTR-
p6D707 and 50LTR-p6D716 sgRNA were truncated to nucleo-
tides 2,270 and 2,183 (Figure 4E), respectively. Probing of these
two protein-free sgRNAs showed substantial destabilization of
P2SL (Figure 4H). Specifically, the 50LTR-p6D707 and 50LTR-
p6D716 sgRNA showed high 1M7 reactivity within residues
forming P2SL. Moreover, nucleotides 2,044–2,049 show
enhanced reactivity compared to 50LTR-p6D868 sgRNA, sug-
gesting they no longer base pair with the segment spanning
nucleotides 2,132–2,137 (Figure 4H). In contrast, nucleotides
2,096–2,098, reactive in the 50LTR-p6D868 sgRNA, were un-
reactive in these sgRNAs and are instead predicted to be
involved in forming an extended, discontinuous P3 hairpin (Fig-
ure 4H). These data suggest that although the GRPE may func-
tion independent of sequence context, both the P2 and P3SL
must bemaintained for enhanced packaging activity. This obser-
vation was confirmed by deleting 996 nt of the gag sequence
(D1091–2085) in 50LTR-p6D996 sgRNA to remove the linear
sequence encoding P2SL, which dramatically reduced pack-
aging (Figure 4F). Again, the nfl-30LTR sgRNAs were encapsi-
dated at a stable level (Figure S4B). Reduced packaging of the
50LTR sgRNA with these internal deletions resulted in decreased
infectivity of U87.CD4.CXCR4 cells (Figure 4G). In the case of the
50LTR-p6D868 sgRNA, increased infectivity (103 IU/ml) was less
than expected considering the high level of 50LTR-p6D868
sgRNA packaging (Figure 4F). As discussed later, intervening
RNA sequences (also hidden in the coding sequence)
may impact other sgRNA functions aside from encapsidation,
such as dimerization, tRNALys,3 placement, or initiation of re-
verse transcription.
Effect of GRPE Secondary Structure on gRNA
Encapsidation, Dimerization, and Virus Infectivity
To further probe the impact of the P2 and P3 stem loops in RNA
packaging, we preformed site-directed mutagenesis based onmeasured by first normalizing for RT activity, serially diluting as described in F
infectious virus is presented as log10 infectious units/ml in (C) and (G). The structur
(H) using the modeling algorithm RNAstructure (Mathews et al., 2004). Full-length
the region proximal to GRPE/RFS was presented in (H). Data in (B), (D), and (F) a
Cell Host &M-fold RNA structure predictions. Mutations (Figure 5A) causing
minor rearrangement in the general structure of both P2 and
P3SL (mu1, mu2, and mu4 in Figure 5B) had minimal effects on
50LTR sgRNA encapsidation (1.1-, 2.2-, and 3.2-fold, respec-
tively) (Figure 5C) and only slight losses in infectivity (Figure 5E).
In contrast, whenM-fold predicted significant changes to P2 and
P3SLwith the 4 nt and 3 nt substitutions inmu3 andmu5 sgRNAs
(Figures 5A and 5B), a 13.5- and 28-fold reduction was observed
in packaging which corresponded to a 560- and 1,400-fold
loss of infectivity, respectively (Figures 5C and 5E). Similar to
previous experiments, the levels of nfl-30LTR sgRNA packaging
remained constant with all the mu 50LTR sgRNAs (Figure 5D).
These studies provided the strongest evidence for the impor-
tance of the P2 and P3SL for sgRNA packaging.
Exploring the Relationship between HIV-1 mRNA
Translation and gRNA Packaging
The GRPE overlaps with the sequences and/or structures
involved in ribosomal frameshifting, but linking factors involved
in translation with processes involved in gRNA packaging will
require more detailed studies. The translation termination factor
eRF1 binds to the termination codon, stops translation via inter-
actions with the ribosome, and helps to initiate the nonsense
RNA decay (NMD) pathway (Nicholson et al., 2010). Previous
studies indicate that siRNA knockdown of eRF1 increased
Gag-Pol synthesis relative to Gag, suggesting increased ribo-
somal frameshifting and loss of infectivity (Kobayashi et al.,
2010).
To explore the possible role of eRF1 and ribosomal frameshift-
ing on gRNA packaging, we downregulated cellular levels of
eRF1 with siRNA (Figure 6A), but failed to observe an increase
in Gag-Pol in virus particles (data not shown). Next, we
measured levels of 50LTR sgRNAs (by qRT-PCR) relative to RT
activity (or relative to p24 content of the virus). When eRF1 was
depleted with siRNA knockdown, the amount of 50LTR sgRNA
increased >10-fold as compared to virus produced in the pres-
ence of scrambled siRNA (Figure 6B). Based on the assumption
of 2,000 Gag dimers per WT virus particles, knockdown of
eRF1 appears to have produced virus particles containing
15–20 genomic RNAs. We performed the same eRF1 knock-
down experiment with an HIV molecular clone (NL4-3 based)
that carries a Gag-interdomain green fluorescent protein (iGFP)
(Hu¨bner et al., 2007). HIV Gag-iGFP was transfected into 293T
cells to produce virus harboring a Gag-GFP fusion. Reductions
in eRF1 (Figure 6C) appear to result in virus particles with more
gRNA per Gag molecule (Figure 6D) as well as brighter fluores-
cence (compare Figures 6E and 6F), suggesting enlarged virus
particles containing more of Gag, Gag-Pol, and gRNA.
gRNA Dimerization, GRPE, and Model of gRNA
Packaging
The following discussion and Figure 7 highlight how ribosomal
frameshifting and gRNA packaging may be tightly regulated.
Dimerization is described as being an early event during gRNAigure 2C, and then adding to U87.CD4.CXCR4 cells (Figure 2D). The level of
e of the sgRNAwas analyzed using SHAPE (Watts et al., 2009) and presented in
in vitro-transcribed 50LTR sgRNA (E) was used for structural probing, but only
re presented as mean ± SEM. See also Figure S4.
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Figure 5. The Role of RNA Secondary Structure in the GRPE/RFS Region on HIV-1 RNA Packaging
(A) Multiple point mutations were introduced to the predicted P2 and P3 stem loops within the GRPE/RFS sequence. (B) The RNA secondary structures in the
GRPE/RFS region of these five mutants were predicted by M-fold (http://mfold.rna.albany.edu/). The five mutant 50LTR sgRNA templates were expressed in
cotransfected 293T cells. Supernatants from these transfected cells were harvested to measure 50LTR sgRNA (C) and nfl-30LTR sgRNA levels (D) by q-RT-PCR.
The same virus-containing supernatant was then equalized for RT activity, serially diluted, and used to infect U87.CD4.CXCR4 cells. The relative infectivity, as
measured by TCID50 assay, is presented as log10 infectious units/ml (E). Data in (C) and (D) are presented as mean ± SEM.
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A Genomic RNA Packaging Element in Retrovirusescapture/transport and linked to the 50UTR (Paillart et al., 2004;
Johnson and Telesnitsky, 2010; Clever and Parslow, 1997;
Skripkin et al., 1994). To determine the impact of GRPE on
gRNA dimerization, we performed in vitro RNA dimerization
experiments using 30LTR and 50LTRRNAs ±GRPE (all containing
the DIS) (Figure S5). We observed efficient in vitro dimerization of
all sgRNAs (either 50LTR- or 30LTR-containing RNAs) regardless
of the presence or absence of the GRPE (Figures S5A and S5C).
In fact, the shortest 50LTR RNA (MA-1208) dimerizes with high
efficiency (>70% in loose dimers) but cannot be packaged effi-
ciently (>51-fold decrease). Oligonucleotides annealing to DIS
could disrupt dimer formation (Figure S5B). These in vitro find-188 Cell Host & Microbe 13, 181–192, February 13, 2013 ª2013 Elseings may or may not reflect HIV-1 gRNA dimerization in the cell
during encapsidation, but our model in Figure 7 now suggests
that GRPE is involved in gRNA encapsidation following loose
dimer formation.
DISCUSSION
Studies starting in the late 1970s discovered that avian and
murine retroviruses preferentially packaged full-length viral
RNA over the pool of cellular RNAs or spliced viral mRNA (Gerwin
and Levin, 1977). Groundbreaking papers by Shank and Linial
(Linial et al., 1978; Shank and Linial, 1980) first describedvier Inc.
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Figure 6. The Effect of eRF1 Knockdown on
Virus Production and gRNA Encapsidation
A pool of three siRNAs against eRF1 effectively
reduces cellular eRF1 expresion level by 70%
prior to 293T transfections as indicated by
western blot analysis (A) and (C) These siRNA-
treated 293T cells were cotransfected with the
pREC-nfl-30LTR along with either pREC-50LTR-
MA1208, pREC-5
0LTR-p6D868, or pREC-50LTR-
RT2845 or transfected with HIV Gag-iGFP. It is
important to note that eRF1 knockdown reduced
all protein levels in the cell 2-fold within 72 hr.
Virus produced from these siRNA-treated,
cotransfected cells was noninfectious for
U87.CD4.CXCR4 cells. The 50LTR sgRNA or
NL4-3 gRNA in virus particles was measured by
qRT-PCR and presented as relative to p24
antigen content (B) and (D). In the presence of
WT levels of eRF1 (SD siRNA treatment), the
virus produced from the cotransfected cells
harbored approximately 1.6 50LTR sgRNA copies
per 2,000 molecules of p24 (or the estimated
size of one HIV-1 particle). With the eRF1
knockdown and the WT pREC-50LTR-RT2845,
there are approximately 19 50LTR sgRNA copies
per 2,000 p24 molecules. Virus derived from transfections with the HIV Gag-iGFP molecular clone (E, eRF1 knockdown; F, WT eRF1) was sucrose-
cushion purified, spread on poly-L-lysine coverslips, and images captured on a Deltavision RT epifluorescent microscope system.
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A Genomic RNA Packaging Element in Retrovirusesa 300 bp region upstream of the gag-pol genes in avian sarcoma
virus (ASV) necessary for preferential packaging of the ASV RNA
genome, and this J still remains the quintessential packaging
element for almost all retroviruses including HIV-1 (Lever et al.,
1989).
By dividing the genome into two sgRNAs (50LTR-nfl and nfl-
30LTR sgRNA), we established a system in which only heterodi-
ploid virus can establish de novo infection following completion
of reverse transcription. In the infected cells, the 50LTR-nfl
sgRNA binds with tRNALys,3 and serves as a template for ()
strong stop DNA but does not contribute to the HIV-1 coding
sequence within the integrated genome. We performed a series
of RNA truncations, deletions, and point mutations within 50LTR-
nfl sgRNA to identify and characterize a previously unrecognized
RNA packaging element at the 30 end of gag. Removing the
GRPE from 50LTR-nfl sgRNA did not impact virus production
from transfected cells but resulted in a >50-fold loss in pack-
aging of 50LTR-nfl sgRNA relative to nfl-30LTR sgRNA, paralleled
by the loss in virus infectivity. Even with this two log decrease,
residual virus infectivity levels suggest that the J/50UTR is
required for low levels of gRNA packaging.
In our system, the nfl-30LTR sgRNA lacks TAR hairpin and
poly(A) loops, shown to have modest effects on gRNA encapsi-
dation (Russell et al., 2003; McBride and Panganiban, 1996;
Clavel and Orenstein, 1990; Rizvi et al., 2010). Vrolijk et al.
propose that these elements (located upstream of SD) must
work in coordination with the major packaging signal, found
only in the unspliced HIV-1 RNA (Vrolijk et al., 2008). We exam-
ined the GRPE effect in the context of a full-length HIV-1 genome
(with both LTRs intact) and found that the deletion of GRPE still
reduced gRNA packaging (Figure 4D). The GPRE deletion with
the bipartite genome system resulted in 14-fold reduction in
gRNA packaging, whereas a 7-fold decrease was observed
with the deletion of GRPE in WT NL4-3. The slightly reducedCell Host &effect of the GRPE with an intact 50LTR suggests a modest
impact of the TAR on gRNA packaging: 2-fold as reported
(Clavel and Orenstein, 1990; McBride and Panganiban, 1996;
Russell et al., 2003). Finally, we discovered that the GRPE is
absent in most single-cycle lentiviral systems used for gene
therapy, biochemical studies, or vaccine development. Pre-
liminary studies suggest that introducing the GRPEwithin a lenti-
viral gene delivery vector, even out of sequence context, can
result in a >10-fold increase in transduction and gene delivery,
which is directly related to increased gRNA encapsidation
(M.C. and E.J.A., unpublished data).
The RNA packaging element is often described as a set
of static, discrete RNA hairpin structures. However, structural
studies involving combination of bioinformatics, enzymatic
probing, and phylogenetic and intramolecular UV-crosslinking
techniques suggest structural transitions involving both local
multiple branched hairpins nearJ aswell as some long-distance
interactions at the 50 end of gRNA (Damgaard et al., 2004; Abbink
and Berkhout, 2003; Huthoff and Berkhout, 2001). Furthermore,
a riboswitch might help to regulate gRNA dimerization and
packaging. NMR studies revealed a long-distance interaction
whereby the DIS interacts with U5 to inhibit the dimerization,
while an alternative conformation releases the AUG start codon
to promote the translation (Lu et al., 2011). We are currently
exploring how the GRPE may factor into this regulation and
promote gRNA packaging. Our preliminary in vitro studies
suggest that the GRPE does not impact RNA dimerization of
either the 50LTR or 30LTR sqRNAs, whereas disruption of the
DIS did prevent dimerization as previously described (Skripkin
et al., 1994). Although loose RNA dimer formation may have
some relation to the in vivo event, there are obviously cellular
and viral factors that are absent in vitro (e.g., NC region of
Gag) that are required for maturation of tight dimers and encap-
sidation (Paillart et al., 2004; Johnson and Telesnitsky, 2010).Microbe 13, 181–192, February 13, 2013 ª2013 Elsevier Inc. 189
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Cell Host & Microbe
A Genomic RNA Packaging Element in RetrovirusesAs described herein, we show that theGRPE cannot act alone for
gRNA packaging but likely involves the J and related 50UTR
sequences.
The importance of the two GRPE stem loops for gRNA pack-
aging was evident with point mutations and deletions of inter-
vening sequences between the GRPE and 50UTR. Efficient
gRNA packaging was maintained with point mutations or dele-
tions that had minor effects on the stability of P2 and P3SL as
revealed by SHAPE analyses. Aside from their role in gRNA
packaging as described here, these two stem loops are also
necessary for ribosomal frameshifting, a mechanism conserved
among all lentiviruses. Most retroviruses employ a readthrough
translation mechanism whereby a transient/infrequent RNA
pseudoknot may stall the ribosome at the UAG stop codon,
leading to a glutamine incorporation (Houck-Loomis et al.,
2011). Although there is no experimental evidence for involve-
ment of RNA pseudoknots in lentiviral frameshifting, in vitro
SHAPE analyses on the static GRPE sequence provide some
support for possible pseudoknot involving the P2 and P3SL,
but this would also infer a complete unwinding of these two
SLs (M.C., K.J.P., S.F.J.L., and E.J.A., unpublished data). We190 Cell Host & Microbe 13, 181–192, February 13, 2013 ª2013 Elsevier Inc.also suspect higher-order structures
between J and GRPE, but at this stage
a series of detailed biochemical studies
involving SHAPE and/or high resolution
NMR are necessary to support these
claims. Nonetheless, biochemical stud-
ies presented herein provide evidence
for intricate transition events designating
an HIV-1 unspliced RNA as (1) an mRNA
for Gag translation or (2) an mRNA
for Gag-Pol translation and gRNA for
encapsidation.
Overlap between the GRPE and the
RFS suggested a possible link between
translation and gRNA packaging. In
relation to translation termination, eRF1
mediates peptidyl-tRNA hydrolysis at
the peptidyl transferase center of the
ribosome to terminate translation. eRF1
also nucleates a host protein complex
involved in 30UTR sensing and the NMD
pathway (Hogg and Goff, 2010). In 2010,
Kobayashi et al. identified eRF1 froma genome-wide siRNA knockdown screen as a putative candi-
date for interactions with ribosomal frameshift site (Kobayashi
et al., 2010). In their studies, eRF1 depletion led to increased
ratio of Gag-Pol:Gag in HIV-infected cells and production of
noninfectious virus. As a preliminary study, we reduced eRF1
expression levels with siRNAs in cells subsequently transfected
with ourWT andGRPEmutant HIV-1 constructs. Reducing eRF1
levels increased encapsidation of HIV-1 gRNA relative to CA p24
levels in the cell-free supernatant. These virus-like particles may
contain >20 times more gRNA than wild-type virus based on an
assumption of 2,000 Gag dimers per virus particle. When using
a virus containing Gag-iGFP, knockdown of eRF1 appears to
mediate production of ‘‘large’’ virus particles with more Gag
(brighter virus particles) andmore gRNA. Based on these prelim-
inary results and positioning of the GRPE, we propose that
Gag-Pol ribosomal frameshifting may prevent the NMD pathway
and designate this unspliced HIV-1 mRNA (destined for transla-
tion of Gag-Pol) as gRNA for encapsidation. Thus, even slight
increases in ribosomal frameshifting and Gag-Pol synthesis
could lead to dramatic increases in gRNA levels and release of
noninfectious virus particles. Figure 7 presents a model on the
Cell Host & Microbe
A Genomic RNA Packaging Element in Retrovirusescontrol of HIV-1 translation, ribosomal frameshifting, and gRNA
packaging by the GRPE/RFS. A complex involving eRF1 may
form at or near the GRPE/RFS during translation. Termination
of translation may initiate mRNA degradation by the NMD
pathway via accumulation of Up-frameshift protein 1 (Upf1) on
the extended 30UTR and thus prevent Gag precursor binding
to this RNA for encapsidation (Hogg and Goff, 2010). In <5%
of translation events on unspliced HIV-1 mRNA, the ribosome
may shift 1 nt at the RFS, clear the GRPE, prevent binding
Upf1-dependent decay complex, and promote interactions of
cytoplasmic poly(A)-binding protein 1 (PABPC1) with eRF1/
eRF3 (Ivanov et al., 2008) to eventually terminate Gag-Pol trans-
lation. This rare event in HIV-1 translationwouldmaintain a stable
unspliced HIV-1 RNA where the GRPEmay be free to participate
in higher-order RNA interactions (possibly with J) and/or
interact with HIV-1 Gag (or additional cellular factors). Thus,
the unspliced mRNA which was used as a template for Gag-
Pol translation would also serve as genomic RNA. This model
also supports the notion that only a few Gag precursor proteins
can bind HIV-1 unspliced mRNA for encapsidation prior to virus
assembly leaving themajority of Gag precursors to form the virus
core during assembly. Again, this process of virus assembly and
correct gRNA encapsidation would be tightly regulated by
GRPE, a highly conserved HIV-1 sequence.
EXPERIMENTAL PROCEDURES
Additional details of the experimental procedures are provided in the
Supplemental Experimental Procedures.
Plasmids
All plasmids in this study were initially prepared using yeast-based recom-
bination/gap repair system as described (Dudley et al., 2009). Details of
base pREC-50LTR and pREC-nfl-30LTR vectors and cloning are provided in
the Supplemental Experimental Procedures.
Transfection and Infection
293T cells were cotransfected with pREC-50LTR and pREC-nfl-30LTR plas-
mids (3 mg of each plasmid) using FuGENE6 (Roche). Cells and cell-free
supernatant were harvested 48 hr posttransfection to measure infectious titers
by RT assay (Gao et al., 2009) and viral protein levels by western blot and p24
antigen capture assays (see the Supplemental Experimental Procedures for
details). Cellular and viral RNAs were extracted using the RNeasy kit (QIAGEN)
and MagMax (Ambion) kits, respectively, to determine levels of HIV-1 RNA
expression and encapsidation. Cytoplasmic and nuclear RNA isolations
were performed using the PARIS Kit (Ambion). Correct fractionation of cyto-
plasmic and nuclear RNA was tested by RT-PCR amplifying the spliced and
unspliced actin (respectively) with theOTR580, OTR581, andOTR582 primers.
Quantitative Real-Time PCR
Cell- and virion-associated RNAs were reverse transcribed using specific
primer Gag 820–796 for 50LTR-cDNA and oligo dt primer (Invitrogen) for nfl-
30LTR c-DNA using Superscript III transcriptase (Invitrogen). The ABI PRISM
7000 sequence detection system (Applied Biosystems) was used for qRT-
PCR amplifications. U5 and U3 target sequences were specifically amplified
using primer pairs and probes described in Figure 3A. 18S ribosomal RNA
was amplified as an internal control for cellular RNA with the forward primer
human R18.seq-948F and reverse primer human R18.seq-1014R, and
detected with probe 6FAM-TAMRA-30 (Table S1). Serial dilutions of plasmid
DNA with known copy numbers provided amplification and quantitation
controls. For 18 s ribosomal RNA standard, Quantuserial dilution of mRNA
Universal 18S Internal Standard (Ambion) was used. Lack of plasmid DNA
contamination from transfection of cells was confirmed by a control excluding
reverse transcriptase (RT).Cell Host &RNA Synthesis and Secondary RNA Structure Prediction Analysis
Briefly, in vitro-transcribed RNAs were purified using MEGAclear kit (Ambion),
and the size and integrity were checked by denaturing formaldehyde agarose
gel electrophoresis. Fluorescently labeled primer (1 ml) was annealed to 2.5
pmols of RNA (Cy5 [+] and Cy5.5 []; 8 mM), then reverse transcribed. Primer
extension products were analyzed using a Beckman CEQ8000 Genetic
Analysis System. Electropherograms were processed using the ShapeFinder
software. 1M7 reactivity at each nucleotide position was normalized as
described (Wilkinson et al., 2008). Resulting data were introduced to the
RNAstructure software as pseudoenergy constraints. Secondary structures
were visualized using PseudoViewer web application (http://pseudoviewer.
inha.ac.kr/). M-fold web server (http://mfold.rna.albany.edu/) was used to
predict secondary structures of RNA mutants.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures, two tables, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article at http://dx.doi.org/10.1016/j.chom.2013.01.007.
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